Application 074819
- Type
- ANDA
- Sponsor
- OXFORD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ETODOLAC | ETODOLAC | TABLET;ORAL | 400MG | No | No |
| 002 | ETODOLAC | ETODOLAC | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074819-001 | ETODOLAC | ETODOLAC | 400MG | TABLET / ORAL | 1997-02-28 | ||
| A074819-002 | ETODOLAC | ETODOLAC | 500MG | TABLET / ORAL | 1998-04-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074819-001 | ETODOLAC | 400MG | TABLET / ORAL | 1997-02-28 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A074819-002 | ETODOLAC | 500MG | TABLET / ORAL | 1998-04-28 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Etodolac | ETODOLAC | Aurobindo Pharma Limited | c74c3c56-a5ac-40b4-974b-c4f4b05c5df9 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Sun Pharmaceutical Industries, Inc. | ec82b108-6a6f-4d1b-82cb-831d4ed36c80 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | TaSun Pharmaceutical Industries, Inc. | 2c5b44b4-78d5-43b2-827d-d2763b6672b3 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | St. Marys Medical Park Pharmacy | 60cb4de0-ed88-a46b-e053-2a91aa0a8b6d | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | REMEDYREPACK INC. | cad9b5ca-a9d4-41d4-aff2-67d0c458aad6 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | PD-Rx Pharmaceuticals, Inc. | 007c55fa-ef8b-4a8e-bfe5-e47c6e5da727 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | St. Mary's Medical Park Pharmacy | 6761e6b1-2399-4643-e053-2991aa0a6f17 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | PD-Rx Pharmaceuticals, Inc. | 41bd86b9-2ef3-49a4-874e-fe8ac6891080 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | PD-Rx Pharmaceuticals, Inc. | 556eaa67-d30d-4095-a981-c65f98d3acdd | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Preferred Pharmaceuticals Inc. | 117b3005-a8ec-4f76-824c-95ec42dc87a1 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Preferred Pharmaceuticals Inc. | 55ae2e78-d803-496b-b66d-af1140312785 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Bryant Ranch Prepack | ea12933b-2280-4a11-a0e3-554194c53c4d | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Bryant Ranch Prepack | 301087e4-f05c-4fd3-8815-c86c6f12ff61 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Bryant Ranch Prepack | a355160d-24c3-4a4d-99ea-84c80ce67f90 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Bryant Ranch Prepack | e7a81661-28a2-40d7-8c90-786629c81e36 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | Bryant Ranch Prepack | 03458123-e27c-4447-9ef3-3bd32481cb97 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| etodolac | ETODOLAC | Ipca Laboratories Limited | f50a93ca-584a-4205-a79b-31bafdd309c2 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | etodolac ETODOLAC |
| etodolac | ETODOLAC | Ipca Laboratories Limited | d583988c-3e7e-4415-b2fd-34049791cd1c | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | etodolac ETODOLAC |
| Etodolac | ETODOLAC | A-S Medication Solutions | 336d5331-4d60-42e2-8cfc-aad57c01eda0 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
| Etodolac | ETODOLAC | A-S Medication Solutions | 00125d63-d8d0-46c5-bdf1-80d2c85eda5a | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | Etodolac ETODOLAC |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67296-0595 | ETODOLAC | etodolac | RedPharm Drug Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 53916 | ORIG | 2018-05-01 |